Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors.AuthorsAdra, Nabil; Vaughn, David J.; Einhorn, Lawrence H.; Hanna, Nasser H.; Funt, Samuel A.; Rosales, Matt; Arozullah, Ahsan; Feldman, Darren R.PublicationInvestigational New Drugs, 2022, Vol 40, Issue 5, p1087ISSN0167-6997Publication typeArticleDOI10.1007/s10637-022-01276-w